[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-358699-105":59,"doc-detail-358699-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","elovl6-inhibits-colorectal-cancer-progression-through-stearic-acid-mediated-mitochondrial-fusion-and-metabolic-reprogramming","Elovl6 Inhibits Colorectal Cancer Progression Through Stearic Acid-Mediated Mitochondrial Fusion and Metabolic Reprogramming","","Lipid metabolic reprogramming drives colorectal cancer, yet the underlying molecular mechanisms and specific lipid enzymes remain unclear. This study identifies Elovl6 (elongation of very-long-chain fatty acid protein 6) as a critical regulator. Elovl6 is significantly down-regulated in colon cancer, with low expression linked to worse prognosis. Functional experiments show Elovl6 suppresses proliferation in vitro and tumor growth in vivo by controlling intestinal microbial homeostasis and coordinating metabolic reprogramming via phospholipid biosynthesis. Stearic acid promotes mitochondrial fusion through stabilization of mitofusin 1, supporting Elovl6 as a therapeutic target and dietary stearic acid as a preventive strategy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/elovl6-inhibits-colorectal-cancer-progression-through-stearic-acid-mediated-mitochondrial-fusion-and-metabolic-reprogramming/358699/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/elovl6-inhibits-colorectal-cancer-progression-through-stearic-acid-mediated-mitochondrial-fusion-and-metabolic-reprogramming/358699.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does Elovl6 play in colorectal cancer progression?","Question",{"text":112,"@type":113},"Elovl6 acts as a tumor-suppressive regulator in colorectal cancer, inhibiting proliferation in vitro and attenuating tumor growth in vivo.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is Elovl6 expression related to patient prognosis?",{"text":117,"@type":113},"Clinical data show Elovl6 is significantly down-regulated in colon cancer tissues, and low Elovl6 expression correlates with unfavorable patient outcomes.",{"name":119,"@type":110,"acceptedAnswer":120},"Through what mechanism does stearic acid derived from Elovl6 affect mitochondria?",{"text":121,"@type":113},"Stéaric acid promotes mitochondrial fusion by stabilizing the mitofusin 1 (Mfn1) protein.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},358699,1790218506,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","CANCER  \nElovl6 inhibits colorectal cancer progression through stearic acid–mediated mitochondrial fusion and metabolic reprogramming  \nZhiqian Bi1†, Xiaoyao Chang1†, Shengyun Zhu1, Shuilian Fu1, Yuzhe Zhang2, Tingting Wang3*, Feng Wang2*, Hongqin Zhuang1*, Zi-Chun Hua1,4,5*  \nLipid metabolic reprogramming is a hallmark of colorectal cancer (CRC), yet the precise molecular mechanisms underlying lipid-mediated oncogenesis and the specific lipid metabolic enzymes involved remain largely elusive. Here, we identify elongation of very-long-chain fatty acid protein 6 (Elovl6) as a critical regulator in CRC progression. Clinical data reveal significant down-regulation of Elovl6 in colon cancer tissues, with low expression levels correlating with unfavorable patient prognosis. We demonstrate that Elovl6 exerts potent tumor-suppressive effects, significantly inhibiting cellular proliferation in vitro and attenuating tumor growth in vivo. Mechanistically, it maintains intestinal microbial homeostasis by preventing the expansion of opportunistic pathogens while simultaneously orchestrating metabolic reprogramming through modulation of phospholipid biosynthesis pathways. Notably, we find that stearic acid, a key Elovl6-derived metabolite, promotes mitochondrial fusion by stabilizing mitofusin 1 protein. These findings not only position Elovl6 as a promising therapeutic target but also suggest that dietary supplementation with stearic acid could represent a viable strategy for CRC prevention and treatment.  \ncopyright © 2026 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. distributed under a creative commons Attribution noncommercial license 4.0 (cc BY-nc) .  \nINTRODUCTION  \nColorectal cancer (CRC) is a common malignant tumor in the digestive system, ranking second and third in terms of incidence and mortality rates worldwide (1, 2). Although genetic predisposition and environmental factors are well-established contributors to CRC pathogenesis (3, 4), the molecular mechanisms underlying tumor progression remain incompletely elucidated. Current clinical management is guided by molecular profiling, using multimodal strategies that combine surgery with systemic chemotherapy, molecularly targeted agents, and immunotherapy for biomarker-selected patients (5, 6) . Despite these therapeutic advances, 5-year survival rates remain unsatisfactory, particularly for patients with advanced disease (7). Faced with the persistent challenges of high incidence, mortality, and limited treatment efficacy, the identification of previously unidentified molecular targets and mechanistic insights into CRC pathogenesis is urgently needed to develop more effective therapeutic and preventive strategies.  \nLipid metabolism reprogramming is increasingly recognized as a hallmark of cancer (8). Accumulating evidence suggests that dysregulation of lipid metabolism, such as abnormal lipid accumulation, lipogenesis, and lipolysis, is closely related to the progression of CRC disease (9–11) . Notably, specific lipid species, including fatty acids (12), cholesterol derivatives (13), and oxylipins (14), have been  \n1the State Key laboratory of Pharmaceutical Biotechnology, college of life Sciences, nanjing University, nanjing, P. R. china. 2department of General Surgery, the First Affiliated hospital of nanjing Medical University (Jiangsu Province hospital), 300 Guangzhou Road, nanjing 210029, P. R. china. 3the State Key laboratory of Pharmaceutical Biotechnology, chemistry and Biomedicine innovation center (chemBic), division of immunology, Medical School, nanjing University, nanjing 210093, P. R. china. 4changzhou high-tech Research institute of nanjing University and Jiangsu target Pharma laboratories inc., changzhou 213164, P. R. china. 5Faculty of Pharmaceutical Sciences, Xinxiang Medical University, Xinxiang 453003, P. R. china.  \n*[corresponding author. email: wang","cbCaisTLsqMmxsDk","https://ap.wps.com/l/cbCaisTLsqMmxsDk","pdf",13922931,17,"English","# Introduction\n## Colorectal cancer background and clinical challenges\n## Lipid metabolism reprogramming in colorectal cancer\n## Elovl6 as a lipid synthesis enzyme and prior evidence\n# Study rationale and experimental approach\n## Elovl6 expression in patient tissues\n## Generation of Elovl6 knockout mouse models\n## Observed effects and mechanistic framework","[{\"question\":\"What role does Elovl6 play in colorectal cancer progression?\",\"answer\":\"Elovl6 acts as a tumor-suppressive regulator in colorectal cancer, inhibiting proliferation in vitro and attenuating tumor growth in vivo.\"},{\"question\":\"How is Elovl6 expression related to patient prognosis?\",\"answer\":\"Clinical data show Elovl6 is significantly down-regulated in colon cancer tissues, and low Elovl6 expression correlates with unfavorable patient outcomes.\"},{\"question\":\"Through what mechanism does stearic acid derived from Elovl6 affect mitochondria?\",\"answer\":\"Stéaric acid promotes mitochondrial fusion by stabilizing the mitofusin 1 (Mfn1) protein.\"}]","Elovl6 Inhibits Colorectal Cancer Progression Through Stearic Acid-Mediated Mitochondrial Fusion and Metabolic Reprogramming | PDF",1790135009,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/109e6041345457805341560523bc8691.webp",983,1250,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dbf8d31492681d6957e31552eb3023dc.webp",982,1249,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/880b09903b87865fba52f53f347ccd7e.webp",981,1248,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88f1da19673b3b50a40737667dac6211.webp",980,1247]